Modern thirty-day operative mortality for surgical resections in lung cancer

Ginsberg, Robert J.; Hill, Lucius D.; Eagan, Robert T.; Thomas, Pascal-Alexandre; Mountain, Clifton F.; Deslauriers, Jean; Fry, Willard A.; Butz, Ralph O.; Goldberg, Melvyn; Waters, Paul F.

doi:10.1016/s0022-5223(19)39080-4

Cited by 588 publications

(122 citation statements)

References 12 publications

Supporting

Mentioning

104

Contrasting

Unclassified

Order By: Relevance

“…The postoperative morbidity and mortality rates in our series of patients with lung cancer were equivalent with previously reported results [1][2][3][4][5]. In our series, the morbidity rate was 24.3% (173 of 711), and did not differ significantly between patients with IPF and those without IPF.…”

Section: Discussionsupporting

confidence: 90%

“…Postperative morbidity and mortality rates in patients with lung cancer have decreased with advances in perioperative management; including improved preoperative patient selection, anesthetic techniques, and postoperative care. Overall morbidity and mortality rates after surgical treatment for lung cancer has been reported to be 17% to 47% and 0.9% to 7.7%, respectively [1][2][3][4][5]. However, some groups of patients remain at a high risk of complication and death.…”

mentioning

confidence: 99%

“…However, some groups of patients remain at a high risk of complication and death. Several clinical studies have shown that the following risk factors increase morbidity and mortality after lung resection: advanced age [1,4], male gender [2], heavy smoking history [2,6], low respiratory function [1][2][3], extended surgery [1,2,5] and diffuse lung disease [7].…”

mentioning

confidence: 99%

See 2 more Smart Citations

Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis

Kawasaki

Nagai

Yoshida

et al. 2002

Journal of Surgical Oncology

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 90%

mentioning

confidence: 99%

See 1 more Smart Citation

Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis

Kawasaki

Nagai

Yoshida

et al. 2002

Journal of Surgical Oncology

View full text Add to dashboard Cite

show abstract

“…Operation-related death occurred in the two cases of PN group. There were five cases of operation-related deaths of a total of 129 pneumonectomies performed during the same period, and this number was also comparable to the previous report [12]. These results thus indicate that bronchoplasty is a safer procedure than a pneumonectomy.…”

Section: Discussionsupporting

confidence: 86%

Comparison of the surgical results of lobectomy with bronchoplasty and pneumonectomy for lung cancer

et al. 1997

View full text Add to dashboard Cite

Background The retrospectively compared sleeve lobectomy (SL) and pneumonectomy (PN) for lung cancer in terms of surgical complications and postoperative disease‐free survival, as well as incidence and pattern of recurrent disease. Methods From 1977 to 1993, 29 patients with primary lung cancer underwent sleeve resection at our institution. The pneumonectomy group consisted of 29 cases that had been selected during the same period according to the following criteria: (1) in a tumor located in the upper lobe, there was no invasion within 1 cm from both the carina and the orifice of the middle and the lower lobe bronchus, whereas in a tumor located in the middle or lower lobe, there was no invasion within 1 cm of the orifice of the upper bronchus, (2) there was no invasion to the trunks of the pulmonary vessels, (3) there was no invasion to any other lobes, (4) a complete resection was achieved. Results No differences were observed between the two groups regarding stage, histological population, or age. The incidence of postoperative complications was 13.7% in the SL group (2 cases each of pneumonia and arrythmia), and 24.1% in the PN group (3 bronchopulmonary fistula, 2 bleeding, 1 instance each of arrythmia and acute cardiac failure, and 2 operation‐related deaths) (P < 0.05). The 3‐year disease‐free survival was 65.7% in SL, 58.8% in PN (no statistical significance in the log‐rank test). Recurrent disease was observed in the local regions of three patients in the SL group and six patients in the PN group, and at distant organs of six patients in the SL group and seven in the PN group. Conclusions These findings thus suggest that as a curative treatment, lobectomy with bronchoplasty may be a safer procedure than pneumonectomy for lung cancer. J. Surg. Oncol. 64:32–35 © 1997 Wiley‐Liss, Inc.

show abstract

“…Ginsberg et al and Deslauriers et al reported high rates of perioperative mortality in elderly patients after surgery. 54,55 Because it is minimally invasive, ablation treatment is an effective method for patients with lung metastases from bone and soft tissue tumors. Nakamura et al performed RFA in 12 elderly patients with lung metastases from osteosarcoma.…”

Section: Ablation Therapy Of Lung Metastases From Bone and Soft Tissumentioning

confidence: 99%

Value of ablation therapy in the treatment of lung metastases

Fan

2017

Thoracic Cancer

View full text Add to dashboard Cite

Tumor metastases are the basic biological characteristics of malignant tumors, and the lungs are the second most prominent metastatic organs in which these develop after the liver. Currently, with the rapid development of ablation technology, ablation therapy as a local treatment is playing an increasingly important role in the treatment of lung metastases. Whether alone or in combination with other treatments, ablation therapy has achieved good therapeutic effects for the treatment of partial lung metastases. This article briefly summarizes the results of current and previous ablation treatments for lung metastases, and focuses on the value of ablation therapy for different kinds of lung metastases.

show abstract

Modern thirty-day operative mortality for surgical resections in lung cancer

Cited by 588 publications

References 12 publications

Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis

Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis

Comparison of the surgical results of lobectomy with bronchoplasty and pneumonectomy for lung cancer

Value of ablation therapy in the treatment of lung metastases

Contact Info

Product

Resources

About